These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 17641368)

  • 1. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.
    Lee SW; Park SH; Kim KW; Choi EK; Shin YM; Kim PN; Lee KH; Yu ES; Hwang S; Lee SG
    Radiology; 2007 Aug; 244(2):479-85. PubMed ID: 17641368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.
    Park SH; Kim PN; Kim KW; Lee SW; Yoon SE; Park SW; Ha HK; Lee MG; Hwang S; Lee SG; Yu ES; Cho EY
    Radiology; 2006 Apr; 239(1):105-12. PubMed ID: 16484355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.
    Limanond P; Raman SS; Lassman C; Sayre J; Ghobrial RM; Busuttil RW; Saab S; Lu DS
    Radiology; 2004 Jan; 230(1):276-80. PubMed ID: 14695401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Unenhanced Computed Tomography Reliable in the Assessment of Macrovesicular Steatosis in Living Liver Donors?
    Haberal KM; Turnaoğlu H; Haberal Reyhan AN
    Exp Clin Transplant; 2019 Dec; 17(6):749-752. PubMed ID: 31666000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT.
    Park YS; Park SH; Lee SS; Kim DY; Shin YM; Lee W; Lee SG; Yu ES
    Radiology; 2011 Mar; 258(3):760-6. PubMed ID: 21212369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
    Hwang I; Lee JM; Lee KB; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):730-8. PubMed ID: 24533869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio.
    Rogier J; Roullet S; Cornélis F; Biais M; Quinart A; Revel P; Bioulac-Sage P; Le Bail B
    Liver Transpl; 2015 May; 21(5):690-5. PubMed ID: 25761371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CT methods for determining graft steatosis in living donor liver transplantation.
    Şeker M; Erol C; Sevmiş Ş; Saka B; Durur Karakaya A
    Abdom Radiol (NY); 2019 Jul; 44(7):2418-2429. PubMed ID: 30937504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrovesicular steatosis in living related liver donors: correlation of biopsy findings with CT liver attenuation index and body mass index.
    Jehangir M; Nazir R; Jang A; Rana A; Rafique S; Dar FS
    Clin Transplant; 2016 Sep; 30(9):1016-20. PubMed ID: 27291347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive evaluation of graft steatosis in living donor liver transplantation.
    Iwasaki M; Takada Y; Hayashi M; Minamiguchi S; Haga H; Maetani Y; Fujii K; Kiuchi T; Tanaka K
    Transplantation; 2004 Nov; 78(10):1501-5. PubMed ID: 15599315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Assessment of Hepatosteatosis in Living-Donor Liver Transplant: Comparison of Liver Attenuation Index and Histopathologic Results.
    Sagir Kahraman A; Karakas HM; Kirimlioglu H; Kahraman B; Yilmaz S; Kirimlioglu V
    Exp Clin Transplant; 2017 Feb; 15(1):69-77. PubMed ID: 26221870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of Unenhanced Computerized Tomography for Detecting Hepatosteatosis in Living Liver Donors.
    Kuzu UB; Gökcan H; Suna N; Özdemir M; Yıldız H; Kaçar S; Turhan N; Ökten S; Bostancı B; Akdoğan M
    Transplant Proc; 2015; 47(6):1854-9. PubMed ID: 26293063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential Liver Donors.
    Adalı G; Bozkurt B; Ceyhan Ö; Server S; Doğusoy GB; Yüzer Y; Tokat Y
    Transplant Proc; 2019 Sep; 51(7):2373-2378. PubMed ID: 31402250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.
    Maruzzelli L; Parr AJ; Miraglia R; Tuzzolino F; Luca A
    Acad Radiol; 2014 Apr; 21(4):507-13. PubMed ID: 24594420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-based visual grading system for assessment of hepatic steatosis: diagnostic performance and interobserver agreement.
    Park HJ; Kim KW; Kwon HJ; Lee S; Kim DW; Moon HH; Song GW; Lee SG
    Hepatol Int; 2022 Oct; 16(5):1075-1084. PubMed ID: 35789473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.
    Boyce CJ; Pickhardt PJ; Kim DH; Taylor AJ; Winter TC; Bruce RJ; Lindstrom MJ; Hinshaw JL
    AJR Am J Roentgenol; 2010 Mar; 194(3):623-8. PubMed ID: 20173137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.
    Byun J; Lee SS; Sung YS; Shin Y; Yun J; Kim HS; Yu ES; Lee SG; Lee MG
    Eur Radiol; 2019 Aug; 29(8):4427-4435. PubMed ID: 30569183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.
    Kim JM; Ha SY; Joh JW; Sinn DH; Jeong WK; Choi GS; Gwak GY; Kwon CHD; Kim YK; Paik YH; Lee JH; Lee WJ; Lee SK; Park CK
    Medicine (Baltimore); 2016 Feb; 95(7):e2718. PubMed ID: 26886612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of the ultrasound attenuation index for noninvasive quantitative estimation of hepatic steatosis.
    Kwon HJ; Kim KW; Lee SJ; Kim SY; Lee JS; Kim HJ; Song GW; Kim SA; Yu ES; Lee J; Hwang S; Lee SG
    J Ultrasound Med; 2013 Feb; 32(2):229-35. PubMed ID: 23341377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.